Effects of Intravenous Acetaminophen in Patients Undergoing Thoracoscopic Surgery

Summary

This is a single-center, randomized, double-blind, placebo-controlled trial. A total of 100 patients, 50 per treatment arm, undergoing minimally invasive thoracic surgery will be randomized 1:1 across 2 treatment arms: Ofiramev® (acetaminophen) injection 1,000 mg (100 mL) plus patient-controlled analgesia (PCA) and 100 mL placebo plus PCA.

Timeline

Start

2018-06-01

Primary completion

2019-06-01

Completion

2019-06-01

Outcome

Outcome not reported

Stopped (Business): “Not funded”

Drugs

Indications

No indication recorded.